| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/10/2001 | CN1060482C Novel polyhydro derivatives of tylosine and process for their preparation |
| 01/10/2001 | CN1060395C Chinese medicinal preparation for treating pulmonary tuberculosis |
| 01/10/2001 | CN1060392C Medicine for curing recurrent stomatocace and Behcet's syndrome |
| 01/10/2001 | CN1060362C Prepn. process of sanitary embolus |
| 01/09/2001 | US6172193 Escape mutant of the surface antigen of hepatitis B virus |
| 01/09/2001 | US6172116 Use of aminoadamantane compounds as immunoregulators |
| 01/09/2001 | US6172110 Acylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof |
| 01/09/2001 | US6172107 Mycophenolate salt disintegrates selectively in intestines |
| 01/09/2001 | US6172096 Administering 4-pyrazolylbenzenesulfonamide derivatives to treat autoimmune diseases |
| 01/09/2001 | US6172084 Quinoline-indole antimicrobial agents, uses and compositions related thereto |
| 01/09/2001 | US6172082 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 01/09/2001 | US6172069 Controlling time of administering |
| 01/09/2001 | US6172059 Controlling particle size |
| 01/09/2001 | US6172048 Composition containing nucleic acids, preparation and uses |
| 01/09/2001 | US6172047 Therapy for nervous system tumors |
| 01/09/2001 | US6172041 Nervous system disorders |
| 01/09/2001 | US6172038 Antipathogenic peptides and compositions comprising them |
| 01/09/2001 | US6171840 LacC from streptococcus pneumoniae |
| 01/09/2001 | US6171838 ratB |
| 01/09/2001 | US6171835 ribH |
| 01/09/2001 | US6171783 Detecting parainfluenza virus-3 and respiratory syncytial virus infection by using fusion protein of antigenic proteins from both viruses |
| 01/09/2001 | US6171777 Decontaminating by contacting with compound, then recovering product; deactivates human immunodeficiency and hepatitis viruses; before transfusions or clinical tests |
| 01/09/2001 | US6171596 Immunostimulants; genetic engineering |
| 01/09/2001 | US6171592 Equine rhinovirus 1 proteins |
| 01/09/2001 | US6171591 Recombinant nodavirus compositions and methods |
| 01/09/2001 | US6171589 Are useful in protecting individuals against infections by species of the genus mycoplama. |
| 01/09/2001 | US6171583 Powdery iodine complexes |
| 01/09/2001 | CA2111854C Orally active antiviral compounds |
| 01/04/2001 | WO2001000877A2 Method of isolation of regulated virulence determinants from bacterial pathogens |
| 01/04/2001 | WO2001000869A2 Arrays of catalytic or pre-catalytic nucleic acids |
| 01/04/2001 | WO2001000857A1 Delivery system |
| 01/04/2001 | WO2001000839A1 Tetanus toxin polypeptides |
| 01/04/2001 | WO2001000837A1 Basb111 polypeptide and polynucleotide from moraxella catharrhalis |
| 01/04/2001 | WO2001000832A1 Methods for making apo-2 ligand using divalent metal ions |
| 01/04/2001 | WO2001000830A1 Sgip peptides |
| 01/04/2001 | WO2001000824A2 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 01/04/2001 | WO2001000812A2 22012, a novel human carboxypeptidase |
| 01/04/2001 | WO2001000790A1 Production of the lipidated form of the peptidoglycan-associated lipoproteins of gram-negative bacteria |
| 01/04/2001 | WO2001000678A1 Human monoclonal antibodies to hiv-1 envelope glycoprotein gp120 |
| 01/04/2001 | WO2001000676A1 Somatostatin agonists |
| 01/04/2001 | WO2001000660A1 INHIBITORS OF THE INTEGRIN αvβ¿6? |
| 01/04/2001 | WO2001000658A1 C-terminal modified (n-substituted)-2-indolylcarbonyldipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 01/04/2001 | WO2001000648A1 Stabilized viral envelope proteins and uses thereof |
| 01/04/2001 | WO2001000640A1 Macrolides |
| 01/04/2001 | WO2001000639A1 Novel sordarin derivative as a therapeutic antimicrobial agent |
| 01/04/2001 | WO2001000635A2 Derivatives of (3s) tetrahydro-3-furanyl (1s,2r)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-(phosphonooxy)propylcarbamate |
| 01/04/2001 | WO2001000626A1 Hexahydropyrrolo[1,2-c]pyrimidines as antiviral, antifungal and/or antitumor agents |
| 01/04/2001 | WO2001000619A1 Novel fluorinated imidazoline benzodioxane, preparation and therapeutic uses thereof |
| 01/04/2001 | WO2001000615A1 Respiratory syncytial virus replication inhibitors |
| 01/04/2001 | WO2001000612A2 Respiratory syncytial virus replication inhibitors |
| 01/04/2001 | WO2001000611A1 Respiratory syncytial virus replication inhibitors |
| 01/04/2001 | WO2001000594A1 Triazole compounds and combinatorial libraries thereof |
| 01/04/2001 | WO2001000587A1 Azolylbenzamides and analogues and their use for treating osteoporosis |
| 01/04/2001 | WO2001000585A1 Pyrazolidinol compounds |
| 01/04/2001 | WO2001000578A1 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof |
| 01/04/2001 | WO2001000558A1 Preparation of substituted cyclopentane and cyclopentene compounds and certain intermediates |
| 01/04/2001 | WO2001000554A2 Naphthoquinone derivatives and their use in the treatment and control of tuberculosis |
| 01/04/2001 | WO2001000247A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 01/04/2001 | WO2001000242A2 Polycation-based bioconjugates |
| 01/04/2001 | WO2001000236A1 Prevention of type 1 diabetes and other non-polio enterovirus diseases |
| 01/04/2001 | WO2001000235A1 Prion protein binding proteins and uses thereof |
| 01/04/2001 | WO2001000234A2 Methods and compositions for engineering of attenuated vaccines |
| 01/04/2001 | WO2001000232A2 Use of cpg as an adjuvant for hiv vaccine |
| 01/04/2001 | WO2001000226A1 Ophthalmic ointments for treating infective eye diseases |
| 01/04/2001 | WO2001000225A1 Hla binding peptides and their uses |
| 01/04/2001 | WO2001000210A1 Reverse-turn mimetics and methods relating thereto |
| 01/04/2001 | WO2001000209A1 Methods of use of fluoroquinolone compounds against bacteria |
| 01/04/2001 | WO2001000199A1 Compounds obtained from salvia species having antiviral activity |
| 01/04/2001 | WO2001000197A2 Methods of treating fungal infections with inhibitors of nad synthetase enzyme |
| 01/04/2001 | WO2001000188A2 Tetrahydroquinolinyl-6-methyldihydrothiadiazinone derivatives and their use for preventing and/or treating anaemia |
| 01/04/2001 | WO2001000151A1 Topical anti-microbial compositions |
| 01/04/2001 | WO2001000045A1 Drinks and foods capable of eliminating helicobacter pylori |
| 01/04/2001 | WO2001000038A1 An effervescent green tea extract formulation |
| 01/04/2001 | WO2001000021A1 Pyrithione biocides enhanced by silver, copper, or zinc ions |
| 01/04/2001 | WO2000063237A3 Pseudomycin analogs |
| 01/04/2001 | WO2000061611A3 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 01/04/2001 | WO2000060082A3 Vesicle associated proteins |
| 01/04/2001 | WO2000058444A3 Adaptation of virus to vertebrate cells |
| 01/04/2001 | WO2000057917A3 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| 01/04/2001 | WO2000057909A3 Attenuated dengue-2 virus vaccine |
| 01/04/2001 | WO2000056358A3 Vaccine against streptococcus pneumoniae capsular polysaccharides |
| 01/04/2001 | WO2000052145A3 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 01/04/2001 | WO2000050433A3 Staphylococcus aureus q13 polynucleotides, polypeptides and methods of use |
| 01/04/2001 | WO2000044761A3 Ketolide antibiotics |
| 01/04/2001 | WO2000039302A3 Improved expression of hiv polypeptides and production of virus-like particles |
| 01/04/2001 | WO2000018354A3 Invaplex from gram negative bacteria, method of purification and methods of use |
| 01/04/2001 | WO1999062451A8 Topical transdermal treatments |
| 01/04/2001 | DE19930557A1 Hydrate von Ciprofloxacin und Verfahren zu ihrer Herstellung Hydrates of ciprofloxacin and processes for their preparation |
| 01/04/2001 | DE19929785A1 Tetrahydrochinolinyl-6-methyldihydrothiadiazinon-Derivate und ihre Verwendung Tetrahydroquinolinyl-6-methyldihydrothiadiazinon derivatives and their use |
| 01/04/2001 | CA2377721A1 Sgip peptides |
| 01/04/2001 | CA2377585A1 Methods for making apo-2 ligand using divalent metal ions |
| 01/04/2001 | CA2377534A1 Delivery system |
| 01/04/2001 | CA2377531A1 Basb111 polypeptide and polynucleotide from moraxella catarrhalis |
| 01/04/2001 | CA2377287A1 Preparation of substituted cyclopentane and cyclopentene compounds and certain intermediates |
| 01/04/2001 | CA2377272A1 Triazole compounds and combinatorial libraries thereof |
| 01/04/2001 | CA2377265A1 Somatostatin agonists |
| 01/04/2001 | CA2377224A1 Inhibitors of the integrin .alpha.v.beta.6 |
| 01/04/2001 | CA2377200A1 Pyrazolidinol compounds |
| 01/04/2001 | CA2377186A1 Novel fluorinated imidazoline benzodioxane, preparation and therapeutic uses thereof |
| 01/04/2001 | CA2377084A1 Methods and compositions for engineering of attenuated vaccines |